|
|
|
By Mark F. Witcher, Ph.D., biopharma operations subject matter expert | Using relational risk analysis, let's take a closer look at risk management plans for identifying and managing adverse reactions for administering a new therapy to a patient. | |
|
|
|
|
| Using Synthesis And Route Design Technology To Approach API Complexity | Article | By Dr. Ryan Littich, Lonza and Dr. Juergen Swienty-Busch, Elsevier Information Systems | Leveraging computer-aided synthesis design technology and route scouting in the early stages of development can aid you in designing an efficient and cost-effective path to API manufacturing. |
|
|
|
| Meet Singota's 'Dr. Impossible' | Article | Singota Solutions | Explore how Dr. Shehaab Savliwala, a leading formulation scientist at Singota Solutions, transforms complex pharmaceutical challenges into breakthroughs and innovative drug delivery. |
|
|
| Sinclair Nanopig For Biopharmaceuticals Safety Assessment | White Paper | By Yafei Chen and Wendell P. Davis, Altasciences | Discover groundbreaking data that supports the use of the Sinclair Nanopig to reduce reliance on traditional non-rodent species in drug development, validating its value in drug safety studies. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|